Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Using data to optimize blood bottle fill volumes and pathogen detection - making blood cultures great again.

Hazen KC, Polage CR.

Clin Infect Dis. 2019 Mar 14. pii: ciz203. doi: 10.1093/cid/ciz203. [Epub ahead of print] No abstract available.

PMID:
30901027
2.

Performance of the Accelerate Diagnostics PhenoTM system with resin-containing BacT/ALERT® Plus blood culture bottles.

Starr KF, Robinson DC, Hazen KC.

Diagn Microbiol Infect Dis. 2019 Jun;94(2):122-128. doi: 10.1016/j.diagmicrobio.2019.01.002. Epub 2019 Jan 16.

PMID:
30718159
3.

Multicenter Clinical Evaluation of BacT/Alert Virtuo Blood Culture System.

Jacobs MR, Mazzulli T, Hazen KC, Good CE, Abdelhamed AM, Lo P, Shum B, Roman KP, Robinson DC.

J Clin Microbiol. 2017 Aug;55(8):2413-2421. doi: 10.1128/JCM.00307-17. Epub 2017 May 24.

4.

Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation.

Baker AW, Lewis SS, Alexander BD, Chen LF, Wallace RJ Jr, Brown-Elliott BA, Isaacs PJ, Pickett LC, Patel CB, Smith PK, Reynolds JM, Engel J, Wolfe CR, Milano CA, Schroder JN, Davis RD, Hartwig MG, Stout JE, Strittholt N, Maziarz EK, Saullo JH, Hazen KC, Walczak RJ Jr, Vasireddy R, Vasireddy S, McKnight CM, Anderson DJ, Sexton DJ.

Clin Infect Dis. 2017 Apr 1;64(7):902-911. doi: 10.1093/cid/ciw877.

5.

Author Correction for Hyman et al., Evaluation of a Fully Automated Research Prototype for the Immediate Identification of Microorganisms from Positive Blood Cultures under Clinical Conditions.

Hyman JM, Walsh JD, Ronsick C, Wilson M, Hazen KC, Borzhemskaya L, Link J, Clay B, Ullery M, Sanchez-Illan M, Rothenberg S, Robinson R, van Belkum A, Dunne WM Jr.

MBio. 2016 May 24;7(3). pii: e00705-16. doi: 10.1128/mBio.00705-16. No abstract available.

6.

Evaluation of a Fully Automated Research Prototype for the Immediate Identification of Microorganisms from Positive Blood Cultures under Clinical Conditions.

Hyman JM, Walsh JD, Ronsick C, Wilson M, Hazen KC, Borzhemskaya L, Link J, Clay B, Ullery M, Sanchez-Illan M, Rothenberg S, Robinson R, van Belkum A, Dunne WM Jr.

MBio. 2016 Apr 19;7(2):e00491-16. doi: 10.1128/mBio.00491-16. Erratum in: MBio. 2016 May 24;7(3):.

7.

Challenges in Preparation of Cumulative Antibiogram Reports for Community Hospitals.

Moehring RW, Hazen KC, Hawkins MR, Drew RH, Sexton DJ, Anderson DJ.

J Clin Microbiol. 2015 Sep;53(9):2977-82. doi: 10.1128/JCM.01077-15. Epub 2015 Jul 15.

8.

The Incidence of Propionibacterium acnes in Open Shoulder Surgery: A Controlled Diagnostic Study.

Mook WR, Klement MR, Green CL, Hazen KC, Garrigues GE.

J Bone Joint Surg Am. 2015 Jun 17;97(12):957-63. doi: 10.2106/JBJS.N.00784.

PMID:
26085528
9.

Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.

Thaden JT, Lewis SS, Hazen KC, Huslage K, Fowler VG Jr, Moehring RW, Chen LF, Jones CD, Moore ZS, Sexton DJ, Anderson DJ.

Infect Control Hosp Epidemiol. 2014 Aug;35(8):978-83. doi: 10.1086/677157. Epub 2014 Jun 20.

10.

Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.

Enfield KB, Huq NN, Gosseling MF, Low DJ, Hazen KC, Toney DM, Slitt G, Zapata HJ, Cox HL, Lewis JD, Kundzins JR, Mathers AJ, Sifri CD.

Infect Control Hosp Epidemiol. 2014 Jul;35(7):810-7. doi: 10.1086/676857. Epub 2014 May 15.

PMID:
24915208
11.

Respiratory fungal infections: molecular diagnostic tests.

Hazen KC.

Clin Lab Med. 2014 Jun;34(2):351-64. doi: 10.1016/j.cll.2014.02.008. Epub 2014 Apr 12. Review.

PMID:
24856532
12.
13.

Successful treatment of osseous blastomycosis without pulmonary or disseminated disease and review of the literature.

Day SR, Weiss DB, Hazen KC, Moore CC.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):242-4. doi: 10.1016/j.diagmicrobio.2014.02.021. Epub 2014 Mar 7. Review.

14.

Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Mathers AJ, Poulter M, Dirks D, Carroll J, Sifri CD, Hazen KC.

Infect Control Hosp Epidemiol. 2014 Apr;35(4):350-5. doi: 10.1086/675603.

PMID:
24602938
15.

Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy.

Moehring RW, Lewis SS, Isaacs PJ, Schell WA, Thomann WR, Althaus MM, Hazen KC, Dicks KV, Lipuma JJ, Chen LF, Sexton DJ.

JAMA Intern Med. 2014 Apr;174(4):606-12. doi: 10.1001/jamainternmed.2013.13768.

PMID:
24493147
16.
17.

Diagnostic accuracy of histopathologic and cytopathologic examination of Aspergillus species.

Shah AA, Hazen KC.

Am J Clin Pathol. 2013 Jan;139(1):55-61. doi: 10.1309/AJCPO8VTSK3HRNUT.

PMID:
23270899
18.

First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world.

Mathers AJ, Hazen KC, Carroll J, Yeh AJ, Cox HL, Bonomo RA, Sifri CD.

J Clin Microbiol. 2013 Feb;51(2):680-3. doi: 10.1128/JCM.02580-12. Epub 2012 Nov 21. Erratum in: J Clin Microbiol. 2013 Apr;51(4):1352.

19.

Influence of DMSO on antifungal activity during susceptibility testing in vitro.

Hazen KC.

Diagn Microbiol Infect Dis. 2013 Jan;75(1):60-3. doi: 10.1016/j.diagmicrobio.2012.09.002. Epub 2012 Oct 6.

PMID:
23044194
20.

Genotyping of Candida parapsilosis from three neonatal intensive care units (NICUs) using a panel of five multilocus microsatellite markers: broad genetic diversity and a cluster of related strains in one NICU.

Reiss E, Lasker BA, Lott TJ, Bendel CM, Kaufman DA, Hazen KC, Wade KC, McGowan KL, Lockhart SR.

Infect Genet Evol. 2012 Dec;12(8):1654-60. doi: 10.1016/j.meegid.2012.06.012. Epub 2012 Jul 5.

PMID:
22771359
21.

Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid.

Mathers AJ, Cox HL, Kitchel B, Bonatti H, Brassinga AK, Carroll J, Scheld WM, Hazen KC, Sifri CD.

MBio. 2011 Nov 1;2(6):e00204-11. doi: 10.1128/mBio.00204-11. Print 2011.

22.

Leuconostoc pseudomesenteroides blood stream infection following liver transplantation.

Tholpady SS, Sifri CD, Sawyer RG, Hazen KC, Pruett TL, Bonatti H.

Ann Transplant. 2010 Jan-Mar;15(1):61-6.

PMID:
20305321
24.

Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents.

Pettit RK, Repp KK, Hazen KC.

Med Mycol. 2010 Mar;48(2):421-6. doi: 10.1080/13693780903136879.

PMID:
19637092
25.

Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients.

Mathers AJ, Cox HL, Bonatti H, Kitchel B, Brassinga AK, Wispelwey B, Sawyer RG, Pruett TL, Hazen KC, Patel JB, Sifri CD.

Transpl Infect Dis. 2009 Jun;11(3):257-65. doi: 10.1111/j.1399-3062.2009.00374.x. Epub 2009 Feb 18.

26.

Moraxella osloensis bacteremia in a kidney transplant recipient.

Sifri CD, Brassinga AK, Flohr T, Kinchen JM, Hazen KC, Sawyer RG, Pruett TL, Bonatti H.

Transpl Int. 2008 Oct;21(10):1011-3. doi: 10.1111/j.1432-2277.2008.00727.x. Epub 2008 Jul 25. No abstract available.

28.

Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth.

Kaufman DA, Gurka MJ, Hazen KC, Boyle R, Robinson M, Grossman LB.

Pediatr Infect Dis J. 2006 Aug;25(8):733-7.

PMID:
16874174
30.

Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.

Wetter TJ, Hazen KC, Cutler JE.

Med Mycol. 2005 Sep;43(6):525-32. Erratum in: Med Mycol. 2006 May;44(3):293-4.

PMID:
16323310
31.

Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.

Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB.

J Pediatr. 2005 Aug;147(2):172-9.

PMID:
16126045
32.

Sterol uptake in Candida glabrata: rescue of sterol auxotrophic strains.

Bard M, Sturm AM, Pierson CA, Brown S, Rogers KM, Nabinger S, Eckstein J, Barbuch R, Lees ND, Howell SA, Hazen KC.

Diagn Microbiol Infect Dis. 2005 Aug;52(4):285-93.

PMID:
15893902
33.

Isolation of cholesterol-dependent Candida glabrata from clinical specimens.

Hazen KC, Stei J, Darracott C, Breathnach A, May J, Howell SA.

Diagn Microbiol Infect Dis. 2005 May;52(1):35-7.

PMID:
15878440
34.

Surface hydrophobicity changes of two Candida albicans serotype B mnn4delta mutants.

Singleton DR, Masuoka J, Hazen KC.

Eukaryot Cell. 2005 Apr;4(4):639-48.

35.

Contribution of cell surface hydrophobicity protein 1 (Csh1p) to virulence of hydrophobic Candida albicans serotype A cells.

Singleton DR, Fidel PL Jr, Wozniak KL, Hazen KC.

FEMS Microbiol Lett. 2005 Mar 15;244(2):373-7.

36.
37.
39.
40.

Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion.

Hazen KC, Baron EJ, Colombo AL, Girmenia C, Sanchez-Sousa A, del Palacio A, de Bedout C, Gibbs DL; Global Antifungal Surveillance Group.

J Clin Microbiol. 2003 Dec;41(12):5623-32.

41.
42.

Antifungal and cancer cell growth inhibitory activities of 1-(3',4',5'-trimethoxyphenyl)-2-nitro-ethylene.

Pettit RK, Hamel E, Verdier-Pinard P, Roberson RW, Hazen KC, Pettit GR, Crews LC.

Mycoses. 2002 Apr;45(3-4):65-74.

PMID:
12000503
43.
44.

Fluconazole prophylaxis against fungal colonization and infection in preterm infants.

Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG.

N Engl J Med. 2001 Dec 6;345(23):1660-6.

45.

Cloning and analysis of a Candida albicans gene that affects cell surface hydrophobicity.

Singleton DR, Masuoka J, Hazen KC.

J Bacteriol. 2001 Jun;183(12):3582-8.

46.

Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.

Espinel-Ingroff A, Bartlett M, Chaturvedi V, Ghannoum M, Hazen KC, Pfaller MA, Rinaldi M, Walsh TJ.

Antimicrob Agents Chemother. 2001 Jun;45(6):1828-35.

47.

Inhibition of hydrophobic protein-mediated Candida albicans attachment to endothelial cells during physiologic shear flow.

Glee PM, Cutler JE, Benson EE, Bargatze RF, Hazen KC.

Infect Immun. 2001 May;69(5):2815-20.

48.

Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.

Hazen KC, Wu JG, Masuoka J.

Infect Immun. 2001 Feb;69(2):779-86.

49.

Evaluation of in vitro susceptibility of dermatophytes to oral antifungal agents.

Hazen KC.

J Am Acad Dermatol. 2000 Nov;43(5 Suppl):S125-9. Review. No abstract available.

PMID:
11044288
50.

Supplemental Content

Loading ...
Support Center